Pharmarise Holdings Corporation

2796

JP3802320006

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
650 ^JPY	+0.46%		-0.31%	-1.52%

Apr. 11	Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	MT
Apr. 10	Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	CI

Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024

April 10, 2024 at 04:00 am EDT

Pharmarise Holdings Corporation revised consolidated earnings guidance for the fiscal year ending May 31, 2024. For the period, the company expects net sales of JPY 54,086 million, operating profit of JPY 1,056 million and profit attributable to owners of parent of JPY 168 million and earnings per share of JPY 16.01.

Latest news about Pharmarise Holdings Corporation

Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	Apr. 10	MT
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	Apr. 10	CI
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	Mar. 14	CI
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.	Jan. 11	CI
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise	Jan. 10	MT
Pharmarise Holdings Corporation authorizes a Buyback Plan.	Jan. 10	CI
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.	Jan. 10	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	Jan. 10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	23-10-11	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	23-10-11	CI
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.	23-08-09	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023	23-07-11	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales	23-04-11	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	23-04-10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	23-04-10	CI
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.	23-02-13	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023	23-01-12	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	23-01-12	CI
Pharmarise's Fiscal Q1 Attributable Profit Soars 75%	22-10-14	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2023	22-10-13	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	22-10-13	CI
Pharmarise Logs 5% Jump in FY22 Attributable Profit, Maintains Final Dividend	22-07-19	MT

Chart Pharmarise Holdings Corporation

Duration

Period

More charts

Company Profile

Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.

Sector

Drug Retailers

Calendar

2024-07-10 - Q4 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PHARMARISE HOLDINGS CORPORATION	-1.52%	46.16M
RAIA DROGASIL S.A.	-12.79%	8.47B
AIN HOLDINGS INC.	+39.05%	1.36B
QOL HOLDINGS CO., LTD.	+8.27%	425M
NIHON CHOUZAI CO.,LTD.	-2.22%	258M
SALUS, LJUBLJANA, D. D.	+10.56%	224M
GREEN CROSS HEALTH LIMITED	-7.34%	84.68M
PETMED EXPRESS, INC.	-47.35%	80.77M
MEDICAL IKKOU GROUP CO.,LTD.	+23.75%	60.88M

Retail - Drugs without Grocery